title: Performance of chromID® CARBA medium for carbapenemases-producing Enterobacteriaceae detection during rectal screening.
abstract: Chromogenic chromID® CARBA medium was compared with CDC method and MacConkey agar with imipenem for its performance in detecting carbapenemase-producing Enterobacteriaceae (CPE) during a faecal screening surveillance program. Double rectal swabs were collected from patients hospitalized in the ICU. One swab was inoculated onto the solid media chromID® CARBA and MacConkey agar with imipenem, while the other was tested according to CDC protocol. Suspected colonies from all procedures were identified to species level and tested for their susceptibility to carbapenems by phenotypic tests. All carbapenem non-susceptible isolates were tested by the modified Hodge test (MHT) and synergy tests. Positive results were confirmed by PCR testing for carbapenemase gene detection. Performance of all three procedures applied was statistically analyzed as compared to MHT and PCR results for the presence of carbapenemase-encoding genes. Out of 177 rectal samples tested, 86 samples were found to contain one or more CPE verified by molecular detection of carbapenemase encoding genes among isolated Enterobacteriaceae. Sensitivity of chromID® CARBA was 96.5 % in clinical samples. Specificity was 91.2 % at the reading level and 100.0 % after Gram staining. chromID® CARBA performed with high accuracy among the phenotypic methods applied, giving early results.
authors.affiliation: Division of Infectious Diseases, School of Medicine, University of Patras, Patras, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Papadimitriou-Olivgeris
authors.forename: C
authors.initials: C
authors.lastname: Bartzavali
authors.forename: M
authors.initials: M
authors.lastname: Christofidou
authors.forename: N
authors.initials: N
authors.lastname: Bereksi
authors.forename: J
authors.initials: J
authors.lastname: Hey
authors.forename: G
authors.initials: G
authors.lastname: Zambardi
authors.forename: I
authors.initials: I
authors.lastname: Spiliopoulou
mesh_terms: D001426:Bacterial Proteins / Q000378:metabolism*; D001431:Bacteriological Techniques / Q000379:methods*; D002863:Chromogenic Compounds / Q000378:metabolism; D003470:Culture Media / Q000737:chemistry*; D004755:Enterobacteriaceae / Q000201:enzymology / Q000302:isolation & purification*; D004756:Enterobacteriaceae Infections / Q000382:microbiology*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D008403:Mass Screening / Q000379:methods; D012680:Sensitivity and Specificity; D001618:beta-Lactamases / Q000378:metabolism*
chemical_list: D001426:Bacterial Proteins; D002863:Chromogenic Compounds; D003470:Culture Media; D001618:beta-Lactamases; C063912:carbapenemase
references.citation: Euro Surveill. 2008 Jan 24;13(4):
references.pmid: 18445397
references.citation: Lancet Infect Dis. 2009 Apr;9(4):228-36
references.pmid: 19324295
references.citation: J Antimicrob Chemother. 2010 Jul;65(7):1319-21
references.pmid: 20395214
references.citation: J Clin Microbiol. 2009 Oct;47(10):3261-5
references.pmid: 19675211
references.citation: J Glob Antimicrob Resist. 2013 Jun;1(2):85-90
references.pmid: 27873583
references.citation: J Clin Microbiol. 2012 Jun;50(6):1841-6
references.pmid: 22461675
references.citation: J Clin Microbiol. 2012 Apr;50(4):1295-302
references.pmid: 22259214
references.citation: J Antimicrob Chemother. 2009 Aug;64(2):348-52
references.pmid: 19525514
references.citation: Clin Infect Dis. 2010 Feb 1;50(3):364-73
references.pmid: 20041768
references.citation: Euro Surveill. 2010 Nov 18;15(46):
references.pmid: 21144429
references.citation: J Clin Microbiol. 2012 Sep;50(9):3102-4
references.pmid: 22760041
references.citation: J Antimicrob Chemother. 2012 Dec;67(12):2976-81
references.pmid: 22927316
references.citation: J Clin Microbiol. 2011 May;49(5):1965-9
references.pmid: 21430097
references.citation: Int J Antimicrob Agents. 2010 Sep;36(3):205-10
references.pmid: 20598859